0001209191-23-033341.txt : 20230601
0001209191-23-033341.hdr.sgml : 20230601
20230601162151
ACCESSION NUMBER: 0001209191-23-033341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230530
FILED AS OF DATE: 20230601
DATE AS OF CHANGE: 20230601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Batycky Alka
CENTRAL INDEX KEY: 0001978041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39971
FILM NUMBER: 23984996
MAIL ADDRESS:
STREET 1: C/O LANDOS BIOPHARMA, INC.
STREET 2: P.O. BOX 11239
CITY: BLACKSBURG
STATE: VA
ZIP: 24062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landos Biopharma, Inc.
CENTRAL INDEX KEY: 0001785345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815085535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 540-818-2844
MAIL ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-30
0
0001785345
Landos Biopharma, Inc.
LABP
0001978041
Batycky Alka
C/O LANDOS BIOPHARMA, INC.
PO BOX 11239
BLACKSBURG
VA
24062
1
0
0
0
0
Stock Option (right to buy)
3.05
2023-05-30
4
A
0
3600
0.00
A
2033-05-29
Common Stock
3600
3600
D
The shares of common stock underlying the option will vest and become exercisable in 36 equal monthly installments beginning on May 30, 2023, subject to the Reporting Person's continuous service with the Issuer on each such date.
/s/ Gregory Oakes, attorney-in-fact
2023-06-01